ArticleCancer science2007
The expression of ezrin in NPC and its interaction with NGX6, a novel candidate suppressor.
Article in Cancer science, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 39 citations in OpenAlex.
- Inhibition of Ezrin suppresses cell migration and invasion in human nasopharyngeal carcinoma.Oncology letters · 2019Article
- Tumor suppressor NGX6 inhibits the growth and metastasis of multiple cancers.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016Review
- NGX6a is degraded through a proteasome-dependent pathway without ubiquitination mediated by ezrin, a cytoskeleton-membrane linker.The Journal of biological chemistry · 2014Article
- Egr-1 regulates the transcription of NGX6 gene through a Sp1/Egr-1 overlapping site in the promoter.BMC molecular biology · 2014Article
- Increased expression of flotillin-2 protein as a novel biomarker for lymph node metastasis in nasopharyngeal carcinoma.PloS one · 2014Article
- Baicalein mediates inhibition of migration and invasiveness of skin carcinoma through Ezrin in A431 cells.BMC cancer · 2011Article
- Differential miRNA expression and their target genes between NGX6-positive and negative colon cancer cells.Molecular and cellular biochemistry · 2010Article
- Identification of a new seven-span transmembrane protein: NGX6a is downregulated in nasopharyngeal carcinoma and is associated with tumor metastasis.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2010Article
- Berberine inhibits metastasis of nasopharyngeal carcinoma 5-8F cells by targeting Rho kinase-mediated Ezrin phosphorylation at threonine 567.The Journal of biological chemistry · 2009Article
- Synergistic effect of indomethacin and NGX6 on proliferation and invasion by human colorectal cancer cells through modulation of the Wnt/beta-catenin signaling pathway.Molecular and cellular biochemistry · 2009Article
- Signaling Transduction Network Mediated by Tumor Suppressor/Susceptibility Genes in NPC.Current genomics · 2009Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 1 institution in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ezrin, the linker between membrane protein and cytoskeleton, plays an important role in the cellular morphology, cytoskeleton reorganization, adhesion, invasion and metastasis. In this study, ezrin was found to express in high levels either in nasopharyngeal carcinoma tissues or in nasopharyngeal carcinoma 5-8F cells and the knockdown of ezrin expression in the 5-8F cells by RNA interferance could reduce invasive ability, suggesting that ezrin is involved in the progression and invasion of nasopharyngeal carcinoma. Nasopharyngeal carcinoma-associated gene 6 is a novel candidate suppressor gene of tumor metastasis, which was originally cloned in nasopharyngeal carcinoma high-frequency heterozygosity loss region 9p21-22 and is down-regulated in nasopharyngeal carcinoma. In the present study, we hypothesize that nasopharyngeal carcinoma-associated gene 6 plays an inhibitory role in the migration and invasion of nasopharyngeal carcinoma cells via modulating the function of ezrin. Firstly, different mutants of NGX6 were constructed and transfected into nasopharyngeal carcinoma 5-8F cells. The invasion and migration of 5-8F cells overexpressing nasopharyngeal carcinoma-associated gene 6 or mutants were measured. The results showed that enhanced expression of nasopharyngeal carcinoma-associated gene 6 could reduce invasive and migratory abilities of 5-8F cells, and the cytoplasmic domain was essential for nasopharyngeal carcinoma-associated gene 6 to modulate cell migration and invasion. Further experiment results showed that nasopharyngeal carcinoma-associated gene 6 protein was associated with ezrin by its cytoplasm region, and it could down-regulate the expression level of ezrin. These results demonstrated that nasopharyngeal carcinoma-associated gene 6 was probably involved in the modulation of invasive and adhesive ability of nasopharyngeal carcinoma cells by down-regulating the expression level of ezrin.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.